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Abstract
Background: Modular polyketide synthases catalyse the bio-
synthesis of medically useful natural products by stepwise chain
assembly, with each module of enzyme activities catalysing a
separate cycle of polyketide chain extension. Domain swapping
between polyketide synthases leads to hybrid multienzymes that
yield novel polyketides in a more or less predictable way. No
experiments have so far been reported which attempt to enlarge a
polyketide synthase by interpolating additional modules.
Results : We describe here the construction of tetraketide
synthases in which an entire extension module from the
rapamycin-producing polyketide synthase is covalently spliced
between the first two extension modules of the erythromycin-
producing polyketide synthase (DEBS). The extended polyketide
synthases thus formed are found to catalyse the synthesis of
specific tetraketide products containing an appropriate extra
ketide unit. Co-expression in Saccharopolyspora erythraea of the
extended DEBS multienzyme with multienzymes DEBS 2 and
DEBS 3 leads to the formation, as expected, of novel octaketide
macrolactones. In each case the predicted products are accom-
panied by significant amounts of unextended products, corre-
sponding to those of the unaltered DEBS PKS. We refer to this
newly observed phenomenon as ‘skipping’.
Conclusions: The strategy exemplified here shows far-reaching
possibilities for combinatorial engineering of polyketide natural
products, as well as revealing the ability of modular polyketide
synthases to ‘skip’ extension modules. The results also provide
additional insight into the three-dimensional arrangement of
modules within these giant synthases. ß 2001 Elsevier Science
Ltd. All rights reserved.
Keywords: Polyketide synthase; Modular; Erythromycin; Rapamycin;
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1. Introduction
Complex polyketides are a large and structurally diverse
class of natural products that includes many compounds
possessing antibiotic or other clinically useful properties.
They are each produced by stepwise chain assembly on a
modular polyketide synthase (PKS). Such PKSs are giant
multienzymes containing a di¡erent set or ‘module’ of en-
zyme domains to accomplish each successive cycle of poly-
ketide chain extension [1,2]. The evident modularity of
these systems, together with numerous reports that pro-
ductive hybrid PKSs may be engineered, by swapping
either one [3^6] or more [7^11] domains between di¡erent
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natural PKSs, has generated increasing interest in the de-
gree to which this modularity might be exploited to make
large numbers of new, potentially valuable natural prod-
ucts. In choosing the points of fusion in such hybrid PKSs,
linker regions are normally selected from within the pro-
nounced domain-and-linker structure of modular PKSs in
solution as predicted by computer-assisted sequence align-
ments [12^14] and determined by limited proteolysis
[15,16] of the puri¢ed multienzymes. It has also proved
fruitful to create such fusions at the margin of a domain,
within regions of conserved sequence [3,8]. Meanwhile, the
importance has also been highlighted of intermodular
transfer [10,11], of chain release [17,18], and of the action
of auxiliary thioesterases [19,20], as potentially rate-limit-
ing steps in polyketide chain synthesis. In this work, we
aimed to gain further insight into the role of intermodular
transfer, by inserting the DNA encoding a complete ex-
tension module, derived from the rapamycin-producing
PKS of Streptomyces hygroscopicus, into the gene encod-
ing the erythromycin-producing PKS of Saccharopoly-
spora erythraea, the 6-deoxyerythronolide B synthase
(DEBS), to produce a molecular assembly line extended
in the middle by one module. Removal of C-terminal
modules was originally accomplished by re-location of
the DEBS chain-terminating thioesterase [21], and almost
all subsequent studies on this enzyme have exploited this
strategy, which leaves the PKS structure relatively unper-
turbed, to select polyketide chain length and to ensure
e⁄cient release of polyketide products. Insertion of an
entire module into the middle of an existing modular as-
sembly presents a signi¢cantly greater challenge to the
structural integrity and proper functioning of the resultant
hybrid. Accordingly, any success in this would be partic-
ularly relevant to the prospects for combinatorial deploy-
ment of individual modules from diverse sources.
The modular PKSs are homodimers [22], with close
functional links between identical modules in the paired
multienzyme subunits [16,23]. We have proposed [16] that
each module interacts with its partner in a con¢guration
which is both head-to-tail and head-to-head, so that the
ketosynthase (KS) and acyltransferase domains from each
module constitute a tetrahedral core. The overall fold of
the PKS in the preferred version of this model is a double-
helical arrangement, in which the chirality of each succes-
sive module pair is identical, for the entire PKS. There is
therefore no stereochemical constraint on modules being
swapped, deleted or inserted to generate functional hybrid
PKS assemblies.
We now report the production of novel tetraketide
products by addition of a complete module into the model
system DEBS1-TE derived from the erythromycin PKS of
S. erythraea [21], a bimodular PKS that normally makes
triketides; and also the production of novel octaketides,
both 16-membered and 14-membered macrolactones, by
addition of a complete module into the intact erythromy-
cin PKS, a hexamodular PKS which normally makes hep-
taketide macrolactones only. Our results demonstrate that
module-by-module assembly of natural PKS modules into
novel multienzymes is a realistic procedure for combina-
torial biosynthesis. The module insertion procedure is not
yet e⁄cient : the major compounds produced by the ex-
tended PKSs were the normal products of the unextended
PKS, a phenomenon we have referred to as ‘skipping’.
2. Results
2.1. Construction of an extended modular tetraketide
synthase
The sequencing of the rapamycin (rap) PKS gene cluster
[14,24,25] provided the genetic material for diverse PKS
modules, for use as spare parts in construction of hybrid
PKSs. For the present experiments, we initially chose to
insert rapamycin PKS modules 2 and 5 into the well-char-
acterised DEBS1-TE system, a truncated bimodular PKS
derived from the ¢rst two extension modules of the DEBS
of S. erythraea (Fig. 1). Both rapamycin modules 2 and
Fig. 1. The structures of erythromycin A and rapamycin. The ketide units introduced through the action of the rapamycin-producing PKS modules 2
and 5 are highlighted. Also highlighted is the site in the erythromycin macrocycle chosen for insertion of the new ketide unit.
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5 normally catalyse the extension of a polyketide chain by
the addition of an acetate unit and stereospeci¢c reduction
to a hydroxyacyl-thioester, before transfer to the next
module for subsequent rounds of chain extension. In
each case, the additional module was spliced into the N-
terminal £anking region of the KS domain of module 2 of
DEBS, at a site not far from the inter-domain linker, and
which introduced no amino acid changes in the amino acid
Fig. 2. Domain structure of DEBS1-TE. A variant DEBS1-TE PKS gene was engineered as a host for module insertion by introduction of a unique
Sse8387I site and a unique HindIII site in the DNA encoding the edges of the KS domain of module 2, without alteration in the amino acid sequence
of the residues speci¢ed (shown in bold type). AT, acyltransferase; ACP, acyl carrier protein; KS, L-ketoacyl synthase; KR, L-ketoacyl reductase;
DH, dehydratase; ER, enoylreductase; TE, thioesterase. LM, Loading Module.
Fig. 3. Domain organisation of (a) the bimodular DEBS1-TE and (b) trimodular synthases obtained by engineered insertion of module 2 of the rapa-
mycin-producing PKS (rap module 2) at the N-terminus of DEBS module 2. Orange spheres represent domains originating from DEBS module 1,
yellow spheres represent domains originating from DEBS module 2, and green spheres represent domains from rap module 2. Also shown are the
full-length products found to be produced in vivo from each multienzyme. The tetraketide synthase in (b) produced the triketide lactone 1 as a major
product.
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sequence (Fig. 2). Standard cloning protocols were used to
obtain rapamycin module 2 as an Sse8387I fragment from
the beginning of KS2 to the beginning of KS3; and to
introduce a unique Sse8387I site into the beginning of
the KS2 in the gene encoding DEBS1-TE. The heterolo-
gous module was then introduced in the correct orienta-
tion to yield an in-frame tetraketide synthase. This new
open reading frame was cloned into the expression vector
pCJR24[26] to give pCJR54. In this expression plasmid,
the tetraketide synthase is placed under the actI promoter
(PactI ) which is under the control of its cognate activator
actII-ORF4.
To assess the productivity of the expanded PKS we used
as hosts S. erythraea NRRL2338 red variant [27] and two
mutant strains derived from it. S. erythraea JC2 [26] is a
strain in which the entire eryA region, encoding the DEBS
multienzymes, has been deleted, except for the DNA en-
coding the C-terminal chain-terminating thioesterase,
which is retained as a region of homology for recombina-
tion. S. erythraea strain No. 5 [28] is de¢cient in deoxy-
sugar biosynthesis and accumulates the aglycones erythro-
nolide B and 6-deoxyerythronolide B.
Protoplast transformation of S. erythraea JC2 with plas-
mid pCJR54 followed by a single recombination event,
into the thioesterase region, yielded the strain S. erythraea
JC2/pCJR54 in which there is a tetraketide synthase lo-
cated in the chromosome under PactI . When grown on
SM3 agar for 16 days S. erythraea JC2/pCJR54 produced
1^2 mg/l amounts of both the expected tetraketide prod-
ucts 1 and 2, representing alternative acetate and propio-
nate starter units, and also the triketide products 3 and 4
shown in Figs. 3 and 4. The ratio of tetraketide to trike-
tide products was approximately 1:20, as judged by gas
chromatography mass spectrometry (GC-MS) analysis.
The overall yields of puri¢ed polyketide products observed
are comparable to yields from a recombinant S. erythraea
in which a chromosomal copy of DEBS1-TE is under the
control of the actinorhodin actI promoter, i.e. 20^40 mg/l
in total. The structures of the triketide products were those
expected if DEBS modules 1 and 2 had been utilised, but
the interpolated rapamycin module had been bypassed
during chain extension.
Extraction of the agar with ethyl acetate, followed by
rigorous puri¢cation, and analysis by high resolution mass
spectrometry and multidimensional 1H nuclear magnetic
resonance spectroscopy, con¢rmed the structure and ster-
eochemistry of the tetraketide 1, with the stereochemistry
of module 1 being deduced from the expected stereochem-
Fig. 4. Domain organisation of hybrid trimodular PKS multienzymes made in this study. The domain organisation of the bimodular PKS DEBS1-TE
is shown for comparison.
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ical outcome of DEBS module 1. The structures of the two
triketides were fully con¢rmed by GC-MS and LC-MS
and comparison with synthetic standards.
The above experiments were repeated, except that the
module inserted into DEBS1-TE was rap module 5, which
was predicted to function exactly as for rap module 2. In
agreement with this, the same novel compounds 1 and 2
were obtained in similar yields, and again the ratio of
novel compounds to the triketide lactones 3 and 4 was
1:20.
2.2. Construction of an octaketide synthase
Protoplast transformation of S. erythraea No. 5 with
the plasmid pCJR54, followed by selection for integration
of the plasmid into the chromosome by homologous re-
combination, could in principle give one of several alter-
native outcomes, because integration might occur in the
region of either DEBS module 1, DEBS module 2, or the
thioesterase domain. Recombinants were sought in which
recombination into the chromosomal copy of ery module
2 had occurred. Such recombination leads to a triketide
synthase under the control of the resident ery PKS pro-
moter, while the octaketide synthase is placed under the
powerful act promoter and its activator. One such re-
combinant was identi¢ed, as con¢rmed by Southern anal-
ysis (data not shown) and named S. erythraea No. 5/
pCJR54. This strain was grown in liquid culture as de-
scribed in Section 5. Extraction of the culture with ethyl
acetate and LC-MS analysis established that two di¡erent
Fig. 5. Hepta- and octaketide macrolactones produced by DEBS and/or the heptamodular PKS multienzymes constructed in this work.
Fig. 6. Domain organisation of hybrid heptamodular PKS multienzymes made in this study. The domain organisation of the hexamodular erythromy-
cin-producing PKS is shown for comparison.
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novel compounds were present with the masses expected
for each of the two predicted octaketide products (con-
taining either acetate or propionate starter units). Eryth-
ronolide B 5 was also present, as the most abundant mac-
rolactone, at about 10 mg/l, the same level as obtained
from a strain carrying the normal DEBS genes under the
control of the actI promoter. Three of the four novel com-
pounds detected were isolated and their structures were
determined by high resolution MS and multidimensional
1H and 13C nuclear resonance spectroscopy. These three
compounds (Figs. 5 and 6) are the expected 16-membered
macrolactones 6 and 7, containing either a propionate or
an acetate starter unit respectively. The third is a 14-mem-
bered macrolactone 8, which is formed from the same
enzyme-bound octaketide as 7, but in which the hydroxyl
at C-13 is used for cyclisation rather than the hydroxyl at
C-15. The corresponding 14-membered macrolactone 9
with a propionate starter was present in relatively small
amounts (less than 1 mg/l) and was not isolated. The 16-
membered macrolactone products were isolated as the
hemiketal forms, whereas the 14-membered product was
isolated as the macrolactone. The ratio of octaketide to
heptaketide products, based on isolated yields, was 1:3.5.
No evidence was obtained for hydroxylation at C-6 of the
16-membered macrolactones or of the 14-membered mac-
rolactone at C-6, the ¢rst step in further processing of 6-
deoxyerythronolide B during erythromycin biosynthesis.
The inability of the C-6 hydroxylase to act on macrolac-
tone 8 indicates a narrow substrate speci¢city for this en-
zyme.
To assess whether these novel aglycones might serve as
substrates for the later enzymes of the erythromycin bio-
synthetic pathway, protoplasts of wild-type S. erythraea
were transformed with plasmid pCJR54. Recombinants
were selected that had undergone homologous recombina-
tion into ery module 2, as con¢rmed by Southern analysis
(data not shown). One such strain, S. erythraea WT/
pCJR54, was fermented and the 16-membered macrolac-
tone products were puri¢ed and characterised as before.
The same macrolactone products 6^9 were again observed,
and no evidence was found for the presence of glycosylat-
ed derivatives of these compounds.
The module insertion experiment was then repeated,
except that the module interpolated was rap extension
module 5, spliced into a unique Sse8387I site at the N-ter-
minus of the KS2 domain in the gene encoding DEBS1-
TE. Recombinants containing the corresponding octa-
ketide synthase in S. erythraea NRRL2338 (red variant)
and the mutant strain S. erythraea No. 5 derived from
it, were fermented and the macrolactone products ex-
tracted and characterised. Again, the novel compounds
6^9 were detected together with substantial amounts
of normal 14-membered macrolactone products, indicat-
ing a high level of skipping in these hybrid PKSs too
(Fig. 6).
2.3. Insertion of rap module2 and rap module 5 at
alternative sites within DEBS1-TE
In further experiments, the DNA for an additional mod-
ule was spliced into the gene for DEBS1-TE using a
unique HindIII site, engineered into the DNA for the link-
er region C-terminal of the KS domain of DEBS module 2
(Fig. 2). This extended PKS contains the ery KS2 fused to
the AT domain of the interpolated rap module (which
extends from rap AT2 to the end of the KS domain of
rap module 3), and the rap KS3 is fused to the N-terminus
of the AT domain of DEBS module 2. Another version of
this extended PKS was created using rap module 5, like-
wise inserted at the HindIII site. The methods used for
cloning, expression, and product analysis were mutantis
mutandis exactly analogous to those given in detail in
Section 5 for insertions at the Sse8387I site. In each case
the pattern of production of tetraketides, and their
skipped products, was found to be exactly the same
(data not shown) as when the module was inserted before
the KS2 domain (Fig. 4).
3. Discussion
3.1. Module insertion yields full-length polyketide products
of the predicted structure
The successful insertion of a complete heterologous
module, in covalent linkage, into the middle of a pre-ex-
isting PKS multienzyme, is one of the most dramatic illus-
trations so far of the modularity of these systems. Also,
the full-length polyketide products proved to have exactly
the predicted structure, given the nature of the inserted
module. As has been frequently observed with previously
engineered hybrid PKSs [5,6,11], the e⁄ciency of produc-
tion of the target compounds was lowered (to about 3^5%)
compared to the production of the normal polyketide
products, although as discussed below the overall produc-
tivity of the hybrids made here was comparable with that
of the normal PKS. In part this loss of e⁄ciency in ob-
taining the target compounds in the present case can be
ascribed to the fact that the incoming module and the
adjacent modules were not matched in terms of the chem-
istry and stereochemistry of the ketide units they insert.
Rather, the modules for insertion were chosen so as to
provide a chemical outcome readily distinguishable from
the normal operation of the parent PKS. It is clear that
the enzymes of both the interpolated rap module, and of
the downstream ery module 2, will be confronted with
substrates that are unnatural, and there may be a loss of
e⁄ciency at both steps.
There was no di¡erence in the outcome when rapamycin
module 5 was substituted for rapamycin module 2, despite
their di¡erent native contexts within the rapamycin PKS.
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This implies that di¡erences in the e⁄ciency of molecular
recognition by each module are not the sole or even the
major determining factor in the lower yield. From re-
combinant S. erythraea expressing the hybrid tetraketide
synthases, cell-free extracts were found to contain poly-
peptides of the expected size for a trimodular PKS, and
at levels somewhat reduced compared to the parent
DEBS1-TE (data not shown) so a lower expression also
may account for some, but again only a part, of the di¡er-
ence.
3.2. Insertion of modules at di¡erent sites
Further experiments were also undertaken in which the
inserted rapamycin PKS module extended not from the
KS domain to the ACP, but rather extended from the
end of the KS domain to the end of the KS domain of
the next module. In other words, the module embraced
either from the AT2 domain to the KS3 domain, or
from the AT5 domain to the KS6 domain, depending on
which module was being used. In these cases the module
was inserted in the DNA encoding the C-terminal of the
ery KS2 domain in the DEBS1-TE, at a unique HindIII
site, to give the expanded trimodular PKS. Fermentation
of strains containing these constructs gave exactly the
same reaction products in about the same yields, as were
seen when insertion was done in the DNA encoding the N-
terminus of the KS2 domain, at a unique Sse8387I site
(Figs. 4 and 6). Although the interpretation is clouded
by uncertainties over the relative expression levels of the
hybrid enzymes, these results demonstrate that module
insertion is not wholly dependent on a uniquely correct
choice of insertion site.
3.3. The observation of skipping in extended modular PKSs
The most striking and unexpected feature of the oper-
ation of the extended PKS multienzymes constructed here
was the observation, in every case, that the major products
of the fermentation were the products of the parent un-
extended PKS. Thus the trimodular PKSs all produced
triketide lactones 3 and 4 in amounts (20^40 mg/l) which
are those expected of the normal DEBS1-TE triketide syn-
thase; and erythronolide B 5 was a major product of the
heptamodular PKSs, in amounts (10 mg/l) not much re-
duced compared to the normal PKS. We have called this
new phenomenon, in which an extension module within a
modular PKS multienzyme is e¡ectively bypassed, ‘skip-
ping’. The ratio of expected to skipped products was mea-
sured at 1:20 for the triketides, and 1:3.5 for the octake-
tides, but these ¢gures are based on isolated yields and the
true ¢gure is likely not di¡erent for the two systems. There
is present in the octaketide-producing strains a DEBS1-TE
gene under the control of the chromosomal ery promoter,
but the e¡ects of enzyme produced from this will be lim-
ited, perhaps marginally reducing the overall yield of mac-
rolactone, or allowing a minor alternative pathway for
production of the normal erythronolides.
At present the mechanism of the skipping phenomenon
is unknown, but two broad types of mechanism can be
distinguished: ¢rst, the formation of the unextended prod-
uct may be dependent on the enzymatic activities of the
interpolated module, which would imply that the extended
PKS is correctly folded overall, but that the condensation
step and/or the recruitment of the extender unit may be
adversely a¡ected. Alternatively, the formation of the un-
extended polyketide products might be independent of the
activity of the incoming module. This might be true if the
structure of the extended PKS is distorted in a major way,
so that direct polyketide chain transfer between the £ank-
ing modules can occur, or if a carrier such as coenzyme A
ferries the polyketide chain between them. It cannot be
ruled out that the reduced yields of the expected products
might have been obtained even if skipping had not oc-
curred. We cannot at present distinguish the case where
the presence of stalled polyketide chains on the PKS (be-
cause of poor activity of the hybrid enzyme) provokes
skipping, from one where the possibility for skipping ac-
tively diverts polyketide chains away from the production
of full-length products.
It has been previously reported that a trimodular PKS
based on the ¢rst three extension modules of the erythro-
mycin PKS synthesises in vitro not only tetraketide prod-
ucts but also triketide lactones 3 and 4, the predicted
products of the operation of modules 1 and 2 only [29].
The thioesterase domain linked covalently to the C-termi-
nus of module 3 was reportedly able to cyclise the triketide
acyl chain faster than the TE domain on its own. An
explanation for these results, in the light of our data, is
that the triketide was passed to the thioesterase via mod-
ule 3, which was skipped. The term skipping has recently
been used [30] to describe the operation of the pikromycin/
methymycin PKS of Streptomyces venezuelae, which is re-
sponsible for the formation of both hexaketide and penta-
ketide products from a single enzyme [19]. Sherman and
his colleagues have shown convincingly that under certain
growth conditions the PKS polypeptide bearing the ¢nal
module is expressed in a truncated form lacking the N-
terminal portion of the KS domain, and that this leads to
pentaketide synthesis [30]. However, it remains to be
proved whether the release of pentaketide is indeed
achieved by premature termination, through alternative
docking of the thioesterase (located at the C-terminus of
module 6) against the ACP of module 5, as proposed.
Possibly, the pentaketide chain might ‘skip’ through mod-
ule 6 to reach the thioesterase, without such major rear-
rangement of the PKS structure.
3.4. Implications of module insertion for structural models
of modular PKSs
The results of module insertion reported here do not
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lend unequivocal support to any of the structural models
that have been advanced for these multienzymes in the
absence of high resolution structural information. How-
ever, as illustrated in Fig. 7, the tetrahedral/helical model
[16], and a variation on it advocated recently [31] both
predict that all module pairs have the same chirality (ar-
bitrarily shown in Fig. 7). An additional module can there-
fore be readily accommodated without gross conforma-
tional changes.
4. Signi¢cance
Modular PKSs are responsible for the biosynthesis of a
wide range of clinically important natural products, in-
cluding antibacterial, antitumour, immunosuppressant
and antiparasitic compounds. As in non-ribosomal peptide
synthetases, the separate set or ‘module’ of enzymes that
together catalyse each successive cycle of chain extension
are encoded together, and are housed together in giant
multienzymes, in the order in which they are used. We
have demonstrated here that genetic engineering may be
used to insert an entire heterologous extension module of
activities into an existing modular PKS, and that the re-
sulting hybrid catalyses the production of a full-length
product with exactly the predicted structure. This ability
to extend PKS assembly lines by insertion provides a new
way in which the individual modules of natural PKSs can
be combined in a combinatorial fashion to generate novel
polyketide libraries as potential leads in drug discovery.
The desired full-length products were found to be accom-
panied by large amounts of ‘skipped’ polyketide products,
produced by an unknown mechanism.
5. Materials and methods
5.1. Chemical analysis
1H NMR spectra were recorded at 500 MHz on a Bruker
AMX-500 or DRX-500. 13C NMR spectra were recorded at
125 MHz on a Bruker AMX-500. 1H and 13C NMR spectra
were referenced internally to CHCl3 (7.27 and 77.5 ppm respec-
tively). J values are given in Hz. GC-MS was performed on a
Finnigan MAT GCQ instrument. Analytical and preparative re-
verse phase high performance liquid chromatography mass spec-
trometry (HPLC-MS) analysis was carried on a Finnigan MAT
LCQ instrument. Analyses were run using either an ES or API-
MS interface and using positive^negative ion mode switching.
Accurate mass data were obtained using a Micromass QTOF
¢tted with an ES source operated in the positive ion mode. The
instrument was calibrated using a polyethylene glycol mixture
(200/400/600/1000) with corrections for drift made with a lock
mass of erythromycin A.
5.2. Bacterial strains and culture conditions
Escherichia coli DH10B (Gibco BRL) was used in all standard
cloning procedures and were grown in 2UTY medium [32,33].
Electrocompetent cells of DH10B were made as described previ-
ously [34]. S. erythraea NRRL2338 (red variant) [27] was the kind
gift of Dr J.M. Weber. S. erythraea mutant strain JC2 (from
which the erythromycin-producing PKS genes have been deleted
apart from the chain-terminating thioesterase domain) has been
described [26] as has S. erythraea mutant strain No. 5, which
accumulates erythronolide B [28]. S. erythraea strains were rou-
tinely maintained on R2T20 [35] and TSB medium (Difco) for
liquid cultures at 30‡C. After V2 weeks on R2T20 agar at 30‡C
spores were harvested and stored in 10% glycerol at 380‡C.
5.3. Plasmids and DNA manipulation procedures
Plasmid pCJR24-S was derived from pCJR24 [26] to eliminate
an unwanted Sse8387I site in the polylinker by digesting with this
enzyme, ¢lling-in and religation. Plasmid pIB103 is a pCJR24-S-
based plasmid containing the DEBS1-TE gene, into which a
unique Sse8387I site (coincident with a unique PstI site) and a
unique HindIII site have been introduced by site-speci¢c muta-
genesis using PCR (Fig. 2). A S. erythraea strain housing this
modi¢ed DEBS1-TE gene was shown in control experiments to
produce the expected triketide lactones in similar amounts to a
Fig. 7. Consequences of insertion of a module into a PKS multienzyme.
Schematic three-dimensional representations of DEBS1-TE based on the
proposed helical model [16]: consecutive module pairs are twisted in the
same sense so there is no restriction on the interpolation of an addition-
al module between two extension modules.
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strain containing DEBS1-TE. Plasmid preparation, restriction-en-
zyme digestion, fragment isolation and cloning were performed
using standard procedures [32,33] PCR was performed using Pwo
polymerase (Boehringer) according to the manufacturer’s instruc-
tions.
5.4. Construction of plasmid pCJR54 for the hybrid synthase
containing rap module 2
DNA encoding extension module 2 of the rapamycin-produc-
ing PKS [14,24] was cloned with £anking Sse8387I sites as fol-
lows: a fragment encoding the N-terminal region, up to a unique
SalI site, was ampli¢ed by PCR using the oligonucleotides 5P-
CGCCGTGTCGACCGTGAACGCCG-3P (reverse) and 5P-GTA-
TGGCCTGCAGGTTGCCGGGTGGGG-3P (forward); a frag-
ment encoding the C-terminal region up to a unique CelII site
was ampli¢ed by PCR using the oligonucleotides 5P-GGTAG-
CCTGCAGGCCATTCCCACG-3P (reverse) and 5P-TCCTGGA-
CGCGCTGGCTGAGCA-3P (forward) (restriction sites are shown
in italics) ; each of these fragments was cloned into SmaI-cut
pUC18 (where the DNA sequence was con¢rmed by sequencing),
then assembled by ligation with a SalI^CelII fragment encoding
the central region of rap module 2. The resulting Sse8387I frag-
ment housing the DNA for all of rap module 2 was then cloned
into plasmid pIB103 which had been linearised with the same
enzyme and treated with phosphatase. A plasmid containing the
correct orientation of the inserted Sse8387I fragment was identi-
¢ed and was named pCJR54.
5.5. Construction of plasmid pIB107 for the hybrid synthase
containing rap module 5
DNA encoding extension module 5 of the rapamycin-PKS
[14,24] was cloned with £anking Sse8387I sites as follows: a frag-
ment encoding the N-terminal region, up to a unique XhoI site,
was ampli¢ed by PCR using the oligonucleotides 5P-ATGG-
CCTGCAGGCTGCCGGGTGGGGTG-3P (forward) and 5P-CC-
CTCGAGACCGAAGAAATACG-3P (reverse); a fragment en-
coding the C-terminal region up to a unique XmnI site was
ampli¢ed by PCR using the oligonucleotides 5P-AGCCTG-
CAGGCCATACCCACGATCGC-3P (reverse) and 5P-GTGAAC-
CGGTTCTGGTGGCCGCGCCG-3P (forward); each of these
fragments was cloned into SmaI-cut pUC18 (where the DNA
sequence was con¢rmed by sequencing), then assembled by liga-
tion with a XhoI^XmnI fragment encoding the central region of
rap module 5. The resulting Sse8387I fragment housing the DNA
for all of rap module 5 was then cloned into plasmid pIB103
which had been linearised with the same enzyme and treated
with phosphatase. A plasmid containing the correct orientation
of the inserted Sse8387I fragment was identi¢ed and was named
plasmid pIB107.
5.6. Construction of S. erythraea strains housing either pCJR54 or
pIB107
Protoplasts of S. erythraea strains NRRL2338, JC2, and No. 5
were transformed with pCJR54 or pIB107 according to the pro-
cedure of Yamamoto et al. [35] as adapted by Gaisser et al. [36].
Transformants were selected on solid medium containing thio-
strepton (25 mg/l).
5.7. Fermentation and extraction
Frozen spore suspension (100 Wl) of each plasmid-bearing S.
erythraea NRRL2338 and No. 5 strain was used to inoculate 50
ml of SV2 seed medium [28] in a 250 ml £ask containing thio-
strepton (25 mg/l). This was grown for 3 days at 30‡C and 250
rpm and used to inoculate seven £asks of 300 ml SM3 production
medium [28] (2% v/v) which was incubated at 28‡C and 250 rpm.
After 7 days the fermentation broths were harvested by centrifu-
gation and the supernatant adjusted to pH 9.5 and extracted with
2 l of ethyl acetate. S. erythraea JC2(pCJR54) was grown on
dishes (8U250 ml) of SM3 agar containing 50 Wg/ml thiostrepton.
After 16 days the plates were extracted with ethyl acetate (ad-
justed to pH 1 with formic acid).
5.8. Isolation and puri¢cation of tetraketide metabolites
The extracts from S. erythraea JC2(pCJR54) were neutralised
and chromatographed on a silica gel column. Appropriate frac-
tions were combined and further puri¢ed by HPLC using a Prod-
igy (Phenomenex) 5W C18 column (250U4.6 mm) eluted at 1 ml/
min 25^80% solvent B over 20 min: solvent A ^ milli-Q water;
solvent B ^ methanol. Fractions of 0.5 ml were collected and
appropriate fractions combined and the solvent removed in vacuo
to yield 2.5 mg of the tetraketide lactone 1. The product was
characterised by high-resolution mass spectrometry and 1H
NMR. 1H NMR (500 MHz, CDCl3) N= 4.33 (ddd, J = 3.0, 5.5
and 11.5, 6-H), 3.68 (ddd, J = 3.8, 9.8 and 11.5, 4-H), 3.59 (ddd,
J = 3.8, 5.1 and 8.1, 2P-H), 2.28 (dq, J = 6.8 and 9.8, 3-H), 2.22
(ddd, J = 3.0, 3.8 and 13.2, 5-H), 1.75 (ddd, J = 11.5, 11.5 and
13.2, 5-H), 1.69 (ddq, J = 3.8, 5.5 and 6.8, 1P-H), 1.52 (ddq,
J = 5.1, 7.3 and 9.8, 3P-H), 1.51 (ddq, J = 7.3, 8.1 and 9.8, 3P-
H), 1.34 (d, J = 6.8, C(3)-Me), 1.01 (d, J = 6.8, C(1P)-Me), 0.95
(t, J = 7.3, 4P-H). All the data were consistent with the proposed
structure and stereochemistry of 1. The triketide lactones 3 and 4
were identi¢ed by comparison of their GC-MS and LC-MS char-
acteristics with authentic samples.
5.9. Isolation and puri¢cation of octaketide metabolites
The extract from the putative octaketide-producing strain of S.
erythraea No. 5 (pCJR54) was removed in vacuo to give 1.3 g of
oil, which was solubilised by addition of ethyl acetate (0.4 ml),
methanol (0.8 ml), 10 mM ammonium acetate (1.2 ml) and ace-
tonitrile : 20 mM ammonium acetate (0.8 ml) (4:1 v/v). The mix-
ture was centrifuged to remove particulate matter and subjected
to preparative HPLC. Separation was achieved using a 7W Kro-
masil C8 column (60U25 mm) connected in series with a Hypersil
C18 BDS column (150U25 mm) eluted at 20 ml/min with a gra-
dient of 0^75% solvent B over 60 min: solvent A ^ milli-Q water
plus 10 ml/l 1 M ammonium acetate; solvent B ^ 80% acetoni-
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trile/water plus 20 ml/l 1 M ammonium acetate. Fractions of 10
ml were collected and the eluate was monitored at 210 nm, then
split for ES-MS analysis (negative ion mode) [28]. The extraction
and identi¢cation of metabolites from S. erythraea strains No. 5
(pIB107), NRRL2338(pCJR54) and NRRL2338(pIB107) was
performed in essentially the same fashion.
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